Status:
COMPLETED
Efficacy of a Multiplex BangasureTM RT-PCR Kit for the Detection of COVID-19
Lead Sponsor:
DR. MALA KHAN
Conditions:
COVID-19
Eligibility:
All Genders
5-70 years
Brief Summary
The outbreak of the severe acute respiratory syndrome (SARS) corona virus (CoV)-2 continues to increase globally. To control the coronavirus disease 2019 (COVID-19) transmission, diagnose is very impo...
Detailed Description
Introduction: The corona virus COVID-19 pandemic is the defining global health crisis of our time and the greatest challenge that have faced since World War Two. The pandemic is much more than a heal...
Eligibility Criteria
Inclusion
- Samples with Positives RT-PCR results with Ct value≤35 for the COVID-19 genes at IEDCR will be selected as COVID-19 positive.
- Samples with negative RT-PCR results with no amplification for the COVID-19 genes at IEDCR will be selected as COVID-19.
Exclusion
- Samples with equivocal/ambiguous RT-PCR results in terms of sigmoidal curve and Ct value will be excluded.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 15 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05190016
Start Date
June 1 2022
End Date
September 15 2022
Last Update
September 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Developing Science and Health Initiatives
Dhaka, Bangladesh, 1212